Enhancement of Dendritic Cell Antigen Cross-Presentation by CpG DNA Involves Type I IFN and Stabilization of Class I MHC mRNA

HOW CELLS RESPOND TO INTERFERONS

Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932 · see citing works

CpG Motifs in Bacterial DNA and Their Immune Effects

Krieg, A. Μ. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,570 · see citing works

Functional Role of Type I and Type II Interferons in Antiviral Defense

Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453 · see citing works

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,350 · see citing works

Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells

Cella, M., Engering, A. J., Pinet, V., Pieters, J., & Lanzavecchia, A. (1997) · Nature · doi:10.1038/42030 · Cited by 1,123 · see citing works

Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7

Marié, I., Durbin, J. E., & Levy, D. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6660 · Cited by 1,049 · see citing works

Immunotherapeutic uses of CpG oligodeoxynucleotides

Klinman, D. M. (2004) · Nature reviews. Immunology · doi:10.1038/nri1329 · Cited by 1,007 · see citing works

A Phagosome-to-Cytosol Pathway for Exogenous Antigens Presented on MHC Class I Molecules

Kovacsovics-Bankowski, M., & Rock, K. L. (1995) · Science · doi:10.1126/science.7809629 · Cited by 884 · see citing works

ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

Guermonprez, P., Saveanu, L., Kleijmeer, M. J., Davoust, J. M., Endert, P. V., & Amigorena, S. (2003) · Nature · doi:10.1038/nature01911 · Cited by 753 · see citing works

TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells

Kaer, L. V., Ashton‐Rickardt, P. G., Ploegh, H. L., & Tonegawa, S. (1992) · Cell · doi:10.1016/s0092-8674(05)80068-6 · Cited by 725 · see citing works

Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA

Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I., & Lanzavecchia, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.821 · Cited by 709 · see citing works

Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.

Shen, Z., Reznikoff, G., Dranoff, G., & Rock, K. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2723 · Cited by 702 · see citing works

Phagosomes are competent organelles for antigen cross-presentation

Houde, M., Bertholet, S., Gagnon, É., Brunet, S., Goyette, G., Laplante, A., Princiotta, M. F., Thibault, P., Sacks, D. L., & Desjardins, M. (2003) · Nature · doi:10.1038/nature01912 · Cited by 700 · see citing works

Localization, Quantitation, and In Situ Detection of Specific Peptide–MHC Class I Complexes Using a Monoclonal Antibody

Porgador, A., Yewdell, J. W., Deng, Y., Bennink, J. R., & Germain, R. N. (1997) · Immunity · doi:10.1016/s1074-7613(00)80447-1 · Cited by 669 · see citing works

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells

Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., & Harding, C. V. (1993) · Nature · doi:10.1038/361359a0 · Cited by 615 · see citing works

The Development of Murine Plasmacytoid Dendritic Cell Precursors Is Differentially Regulated by FLT3-ligand and Granulocyte/Macrophage Colony-Stimulating Factor

Gilliet, M. F., Boonstra, A., Paturel, C., Antonenko, S. V., Xu, X.-L., Trinchieri, G., O’Garra, A., & Liu, Y. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020045 · Cited by 524 · see citing works

Toll-like receptors induce a phagocytic gene program through p38

Doyle, S. E., O'Connell, R. M., Miranda, G. A., Vaidya, S. A., Chow, E. K., Liu, P. T., Suzuki, S., Suzuki, N., Modlin, R. L., Yeh, W.-C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031237 · Cited by 433 · see citing works

Cellular mechanisms governing cross-presentation of exogenous antigens

Ackerman, A. L., & Cresswell, P. (2004) · Nature Immunology · doi:10.1038/ni1082 · Cited by 394 · see citing works

Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.

Harding, C. V., & Song, R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.4925 · Cited by 385 · see citing works

Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens

Ackerman, A. L., Kyritsis, C., Tampé, R., & Cresswell, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735556100 · Cited by 383 · see citing works

CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants

Lipford, G. B., Bauer, M., Blank, C. A., Reiter, R., Wagner, H., & Heeg, K. M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270931 · Cited by 378 · see citing works

A Subset of Toll-Like Receptor Ligands Induces Cross-presentation by Bone Marrow-Derived Dendritic Cells

Datta, S. K., Redecke, V., Prilliman, K. R., Takabayashi, K., Corr, M., Tallant, T. C., DiDonato, J. A., Dziarski, R., Akira, S., Schoenberger, S. P., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4102 · Cited by 300 · see citing works

p38 Mitogen-Activated Protein Kinase-Dependent and -Independent Signaling of mRNA Stability of AU-Rich Element-Containing Transcripts

Frevel, M. A. E., Bakheet, T. M., Silva, A. M., Hissong, J. G., Khabar, K. S. A., & Williams, B. R. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.425-436.2003 · Cited by 288 · see citing works

Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism

Cho, H. J., Takabayashi, K., Cheng, P.-M., Nguyen, M.-D., Corr, M., Tuck, S. P., & Raz, E. (2000) · Nature Biotechnology · doi:10.1038/75365 · Cited by 257 · see citing works

Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells

Rescigno, M., Citterio, S., Théry, C., Rittig, M. G., Medaglini, D., Pozzi, G., Amigorena, S., & Ricciardi‐Castagnoli, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5229 · Cited by 251 · see citing works

Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell Maturation

Delamarre, L., Holcombe, H. R., & Mellman, I. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021542 · Cited by 247 · see citing works

Murine Plasmacytoid Pre-Dendritic Cells Generated from Flt3 Ligand-Supplemented Bone Marrow Cultures Are Immature APCs

Brawand, P., Fitzpatrick, D. R., Greenfield, B. W., Brasel, K., Maliszewski, C. R., & Smedt, T. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6711 · Cited by 239 · see citing works

Lipopolysaccharide-induced Expression of Interferon-β Mediates the Timing of Inducible Nitric-oxide Synthase Induction in RAW 264.7 Macrophages

Jacobs, A. T., & Ignarro, L. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106639200 · Cited by 197 · see citing works

Transcriptional regulation of antigen presentation

van den Elsen, P. J., Holling, T. M., Kuipers, H. F., & van der Stoep, N. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.015 · Cited by 172 · see citing works

Roles of proteasomes, transporter for antigen presentation (TAP), and β 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway

Song, R., & Harding, C. V. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.11.4182 · Cited by 162 · see citing works

CpG DNA Induces Maturation of Dendritic Cells with Distinct Effects on Nascent and Recycling MHC-II Antigen-Processing Mechanisms

Askew, D. S., Chu, R. S., Krieg, A. Μ., & Harding, C. V. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6889 · Cited by 126 · see citing works

IFN-αβ Promote Priming of Antigen-Specific CD8+ and CD4+ T Lymphocytes by Immunostimulatory DNA-Based Vaccines

Cho, H. J., Hayashi, T., Datta, S. K., Takabayashi, K., Uden, J. H. V., Horner, A. A., Corr, M., & Raz, E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4907 · Cited by 111 · see citing works

Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator

Pai, R. K., Askew, D. S., Boom, W. H., & Harding, C. V. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1326 · Cited by 107 · see citing works

Phagosomes Are Fully Competent Antigen-Processing Organelles That Mediate the Formation of Peptide:Class II MHC Complexes

Ramachandra, L., Song, R., & Harding, C. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3263 · Cited by 85 · see citing works

High IL-13 production by human neonatal T cells: neonate immune system regulator?

Ribeiro-do-Couto, L. M., Boeije, L. C. M., Kroon, J., Hooibrink, B., Breur-Vriesendorp, B. S., Aarden, L. A., & Boog, C. J. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11 · Cited by 80 · see citing works

Phagocytic processing of antigens for presentation by MHC molecules

Harding, C. V. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)88959-x · Cited by 60 · see citing works

Processing of Exogenous Antigens for Presentation by Class I MHC Molecules Involves Post-Golgi Peptide Exchange Influenced by Peptide-MHC Complex Stability and Acidic pH

Chefalo, P. J., & Harding, C. V. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1274 · Cited by 59 · see citing works

Tapasin−/− and TAP1−/− Macrophages Are Deficient in Vacuolar Alternate Class I MHC (MHC-I) Processing due to Decreased MHC-I Stability at Phagolysosomal pH

Chefalo, P. J., Grandea, A. G., Kaer, L. V., & Harding, C. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.5825 · Cited by 53 · see citing works

Flow analysis of MHC molecules and other membrane proteins in isolated phagosomes

Ramachandra, L. S., Sramkoski, R. M., Canaday, D. H., Boom, W. H., & Harding, C. V. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00017-9 · Cited by 32 · see citing works

Alternative processing for MHC class I presentation by immature and CpG‐activated dendritic cells

Chen, L., & Jondal, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324359 · Cited by 24 · see citing works

Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)

(2002) · doi:10.1002/1521-4141(200208)32:8

Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling

Shi, Y., Zheng, W., Yang, K., Harris, K. G., Ni, K., Xue, L., Lin, W., Chang, E. B., Weichselbaum, R. R., & Fu, Y. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192282 · Cited by 409 · see citing works

Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I

Pucchio, T. D., Chatterjee, B., Smed‐Sörensen, A., Clayton, S., Palazzo, A., Montes, M., Xue, Y., Mellman, I., Banchereau, J., & Connolly, J. E. (2008) · Nature Immunology · doi:10.1038/ni.1602 · Cited by 290 · see citing works

A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis

Dey, B., Dey, R. J., Cheung, L. S., Pokkali, S., Guo, H., Lee, J., & Bishai, W. R. (2015) · Nature Medicine · doi:10.1038/nm.3813 · Cited by 263 · see citing works

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production

Meyer‐Wentrup, F. A. G., Benítez‐Ribas, D., Tacken, P. J., Punt, C. J. A., Figdor, C. G., de Vries, I. J. M., & Adema, G. J. (2008) · Blood · doi:10.1182/blood-2007-03-081398 · Cited by 268 · see citing works

Type I IFN Drives a Distinctive Dendritic Cell Maturation Phenotype That Allows Continued Class II MHC Synthesis and Antigen Processing

Simmons, D. P., Wearsch, P. A., Canaday, D. H., Meyerson, H. J., Liu, Y. C., Wang, Y., Boom, W. H., & Harding, C. V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101313 · Cited by 186 · see citing works

Human Toll‐like receptor‐dependent induction of interferons in protective immunity to viruses

Zhang, S., Jouanguy, E., Sancho‐Shimizu, V., von Bernuth, H., Yang, K., Abel, L., Pïcard, C., Puel, A., & Casanova, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00564.x · Cited by 166 · see citing works

Type I Interferons as Regulators of Human Antigen Presenting Cell Functions

Gessani, S., Conti, L., Cornò, M. D., & Belardelli, F. (2014) · Toxins · doi:10.3390/toxins6061696 · Cited by 107 · see citing works

NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction

Miller, J. S., Warren, E. H., van den Brink, M. R. M., Ritz, J., Shlomchik, W. D., Murphy, W. J., Barrett, A. J., Kolb, H. J., Giralt, S. A., Bishop, M. R., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.02.005 · Cited by 106 · see citing works

Crosstalk between Mycobacterium tuberculosis and the host cell

Dey, B., & Bishai, W. R. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.002 · Cited by 89 · see citing works

Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen‐processing machinery components in a murine model for human papilloma virus 16‐associated tumours

Manning, J. E., Indrová, M., Lubyová, B., Přibylová, H., Bieblová, J., Hejnar, J., Šímová, J., Jandlová, T., Bubenik, J., & Reiniš, M. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02689.x · Cited by 88 · see citing works

Post-transcriptional control of the interferon system

Khabar, K. S. A., & Young, H. A. (2007) · Biochimie · doi:10.1016/j.biochi.2007.02.008 · Cited by 82 · see citing works

Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation

Emmons, J., Townley-Tilson, W. H. D., Deleault, K. M., Skinner, S. J., Gross, R., Whitfield, M. L., & Brooks, S. A. (2008) · RNA · doi:10.1261/rna.748408 · Cited by 82 · see citing works

Neonatal and adult microglia cross‐present exogenous antigens

Beauvillain, C., Donnou, S., Jarry, U., Scotet, M., Gascan, H., Delneste, Y., Guermonprez, P., Jeannin, P., & Couez, D. (2008) · Glia · doi:10.1002/glia.20565 · Cited by 70 · see citing works

Mycobacterium tuberculosis and TLR2 Agonists Inhibit Induction of Type I IFN and Class I MHC Antigen Cross Processing by TLR9

Simmons, D. P., Canaday, D. H., Liu, Y., Li, Q., Huang, A. Y.-C., Boom, W. H., & Harding, C. V. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904005 · Cited by 73 · see citing works

Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion

Kingham, T. P., Chaudhry, U. I., Plitas, G., Katz, S. C., Raab, J. R., & DeMatteo, R. P. (2007) · Hepatology · doi:10.1002/hep.21457 · Cited by 69 · see citing works

Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation

Wang, X., Li, H., Matte-Martone, C. C., Cui, W., Li, N., Tan, H. S., Roopenian, D. C., & Shlomchik, W. D. (2011) · Blood · doi:10.1182/blood-2011-06-358747 · Cited by 54 · see citing works

Pattern recognition receptors and coordinated cellular pathways involved in tuberculosis immunopathogenesis: Emerging concepts and perspectives

Mishra, A., Akhtar, S., Jagannath, C., & Khan, A. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.05.001 · Cited by 49 · see citing works

The paradox of radiation and T cells in tumors

Gough, M. J., & Crittenden, M. R. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100808 · Cited by 48 · see citing works

TLR7 Triggering with Polyuridylic Acid Promotes Cross-Presentation in CD8α+ Conventional Dendritic Cells by Enhancing Antigen Preservation and MHC Class I Antigen Permanence on the Dendritic Cell Surface

Crespo, M. I., Zacca, E. R., Núñez, N. G., Ranocchia, R. P., Maccioni, M., Maletto, B. A., Pistoresi-Palencia, M. C., & Morón, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1102725 · Cited by 48 · see citing works

IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity

Lattanzi, L., Rozera, C., Marescotti, D., D’Agostino, G., Santodonato, L., Cellini, S., Belardelli, F., Gavioli, R., & Ferrantini, M. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.10.003 · Cited by 48 · see citing works

Rapid transit in the immune cells: the role of mRNA turnover regulation

Khabar, K. S. A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207109 · Cited by 44 · see citing works

Topical resiquimod promotes priming of CTL to parenteral antigens

Chang, B. A., Cross, J. L., Najar, H. M., & Dutz, J. P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.062 · Cited by 42 · see citing works

CpG-B ODNs potently induce low levels of IFN-αβ and induce IFN-αβ-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs

Gray, R. C., Kuchtey, J., & Harding, C. V. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006606 · Cited by 37 · see citing works

Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: Importance of a TLR9 agonist and CD4+ T cells

de Alencar, B. C., Araújo, A. F., Penido, M. L. O., Gazzinelli, R. T., & Rodrigues, M. M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.022 · Cited by 35 · see citing works

The role of gut microbiota and probiotics in preventing, treating, and boosting the immune system in colorectal cancer

Masheghati, F., Asgharzadeh, M. R., Jafari, A., Masoudi, N., & Maleki, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122529 · Cited by 36 · see citing works

Intestinal microbiota: A potential target for enhancing the antitumor efficacy and reducing the toxicity of immune checkpoint inhibitors

Luo, B., Zhang, Y., Zhang, C., Liu, X., & Shi, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.001 · Cited by 33 · see citing works

CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells

Parilla, N. W., Hughes, V. S., Lierl, K. M., Wong, H. R., & Page, K. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-84 · Cited by 33 · see citing works

Targeting Dendritic Cells in Allergen Immunotherapy

Novak, N. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.02.010 · Cited by 29 · see citing works

Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4+ T Cell-Independent CD8+ T-Cell Response Against Unconjugated Protein Antigen

Chiodetti, A. L., Vallecillo, M. F. S., Dolina, J. S., Crespo, M. I., Marín, C., Schoenberger, S. P., Allemandi, D. A., Palma, S. D., Pistoresi-Palencia, M. C., Morón, G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02319 · Cited by 26 · see citing works

Deciphering the role of cDC2s in Sjögren's syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity

Lopes, A. P., Hillen, M. R., Hinrichs, A. C., Blokland, S. L. M., Bekker, C. P. J., Pandit, A., Kruize, A. A., Radstake, T. R. D. J., & van Roon, J. A. G. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-222728 · Cited by 25 · see citing works

Circumvention of regulatory CD4+ T cell activity during cross‐priming strongly enhances T cell‐mediated immunity

Heit, A., Gebhardt, F. E., Lahl, K., Neuenhahn, M., Schmitz, F., Anderl, F., Wagner, H., Sparwasser, T. D., Busch, D. H., & Kastenmüller, K. (2008) · European Journal of Immunology · doi:10.1002/eji.200737966 · Cited by 24 · see citing works

CTL induction by cross‐priming is restricted to immunodominant epitopes

Pavelic, V., Matter, M. S., Mumprecht, S., Breyer, I., & Ochsenbein, A. F. (2009) · European Journal of Immunology · doi:10.1002/eji.200838901 · Cited by 23 · see citing works

An innate immune response to adeno-associated virus genomes decreases cortical dendritic complexity and disrupts synaptic transmission

Suriano, C. M., Kumar, N., Verpeut, J. L., Ma, J., Jung, C., Dunn, C. E., Carvajal, B. V., Nguyen, A. V., & Boulanger, L. M. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.03.036 · Cited by 21 · see citing works

Topical TLR9 agonists induce more efficient cross‐presentation of injected protein antigen than parenteral TLR9 agonists do

Najar, H. M., & Dutz, J. P. (2007) · European Journal of Immunology · doi:10.1002/eji.200636212 · Cited by 21 · see citing works

CpG-B Oligodeoxynucleotides Inhibit TLR-Dependent and -Independent Induction of Type I IFN in Dendritic Cells

Liu, Y. C., Gray, R. C., Hardy, G. A. D., Kuchtey, J., Abbott, D. W., Emancipator, S. N., & Harding, C. V. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903079 · Cited by 20 · see citing works

Coadministration of Polyinosinic:Polycytidylic Acid and Immunostimulatory Complexes Modifies Antigen Processing in Dendritic Cell Subsets and Enhances HIV Gag-Specific T Cell Immunity

Quinn, K. M., Yamamoto, A., Costa, A. D. S., Darrah, P. A., Lindsay, R. W. B., Hegde, S. T., Johnson, T. R., Flynn, B. J., Loré, K., & Seder, R. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301730 · Cited by 20 · see citing works

Therapeutic injection of C-class CpG ODN in draining lymph node area induces potent activation of immune cells and rejection of established breast cancer in mice

Yang, L., Sun, L., Wu, X., Wang, L., Wei, H., Wan, M., Zhang, P., Yu, Y., & Wang, L. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.01.011 · Cited by 20 · see citing works

The Content of CpG-DNA in Antigen-CpG Conjugate Vaccines Determines Their Cross-Presentation Activity

Clauson, R. M., Berg, B., & Chertok, B. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00091 · Cited by 20 · see citing works

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells

Shen, K., Liu, H., Yan, W.-L., Wu, C.-C., Lee, M.-H., Leng, C.-H., & Liu, S. (2020) · Cancers · doi:10.3390/cancers12040810 · Cited by 20 · see citing works

Cyclooxygenase-2 Inhibition Promotes Enhancement of Antitumor Responses by Transcutaneous Vaccination with Cytosine-Phosphate-Guanosine-Oligodeoxynucleotides and Model Tumor Antigen

Inoue, J., & Aramaki, Y. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700656 · Cited by 19 · see citing works

Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C)

Schmidt, S., Pedersen, G. K., Neustrup, M. A., Korsholm, K. S., Rades, T., Andersen, P. L., Foged, C., & Christensen, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00898 · Cited by 18 · see citing works

The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors

Blair, T. C., Alice, A. F., Zebertavage, L., Crittenden, M. R., & Gough, M. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653625 · Cited by 18 · see citing works

Cancer Immunotherapy Employing an Innovative Strategy to Enhance CD4+ T Cell Help in the Tumor Microenvironment

Song, L., Yang, M.-C., Knoff, J. S., Wu, T. ‐., & Hung, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115711 · Cited by 18 · see citing works

Presentation of Type B Peptide–MHC Complexes from Hen Egg White Lysozyme by TLR Ligands and Type I IFNs Independent of H2-DM Regulation

Strong, B., & Unanue, E. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100152 · Cited by 18 · see citing works

Enhancement of antigen-specific CD4+ and CD8+ T cell responses using a self-assembled biologic nanolipoprotein particle vaccine

Weilhammer, D. R., Dunkle, A. D., Blanchette, C., Fischer, N. O., Corzett, M., Lehmann, D., Boone, T. J., Hoeprich, P. D., Driks, A., & Rasley, A. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.02.004 · Cited by 18 · see citing works

A novel post-transcriptional role for ubiquitin in the differential regulation of MHC class I allotypes

Cano, F., & Lehner, P. J. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.10.015 · Cited by 17 · see citing works

Adeno-associated virus (AAV) reduces cortical dendritic complexity in a TLR9-dependent mannerPreprint

Suriano, C. M., Verpeut, J. L., Kumar, N., Ma, J., Jung, C., & Boulanger, L. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.28.462148 · Cited by 17 · see citing works

A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon

Yi, J., Lin, P., Li, Q., Zhang, A., & Kong, X. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.08.010 · Cited by 13 · see citing works

Immunization with MHC class I-negative but not -positive HPV16-associated tumour cells inhibits growth of MHC class I-negative tumours

Reiniš, M., Šímová, J., Indrová, M., Bieblová, J., Přibylová, H., Moravcová, S., Jandlová, T., & Bubenik, J. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.1011 · Cited by 12 · see citing works

Distinctive CD8+ T cell activation by antigen-presenting plasmacytoid dendritic cells compared to conventional dendritic cells

van der Sluis, R. M., García‐Rodríguez, J. L., Nielsen, I. H., Gris‐Oliver, A., Becker, J., Costa, B., Chaudhry, M. Z., Werner, M., Laustsen, A., Pedersen, J. G., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115413 · Cited by 10 · see citing works

Characterization of Bacillus anthracis Spore Proteins Using a Nanoscaffold Vaccine Platform

Weilhammer, D. R., Dunkle, A. D., Boone, T. J., Gilmore, S. F., Khemmani, M., Peters, S. K. G., Hoeprich, P. D., Fischer, N. O., Blanchette, C., Driks, A., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01264 · Cited by 8 · see citing works

Expression of IFN-γ induced by CpG-DNA stimulation in a human myeloid leukemia cell line KG-1

Kim, D., Lee, Y., & Kwon, H. (2013) · Journal of the Korean Society for Applied Biological Chemistry · doi:10.1007/s13765-013-3171-0 · Cited by 3 · see citing works

Effects of CpG-ODNs on phenotype and function of monocyte-derived dendritic cells in chronic hepatitis B

Xiang, X. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i43.4825 · Cited by 3 · see citing works

Innate Cellular Immune Responses in HIV Infection

Schmidt, B., Kittan, N. A., Haupt, S., & Levy, J. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-33785-2_8 · Cited by 2 · see citing works

A transcriptomic approach for studying the activation ofdendritic cells in response to mycobacterial infections

Krishnan, N. (2007) · Doctoral thesis, University of London. · Cited by 1 · see citing works

Novel amphiphilic polyanhydrides for vaccine delivery

Torres-González, M. D. P. (2008) · doi:10.31274/rtd-180813-16976

Untersuchungen zur Effizienz von DNA-und Protein-Trägersystemen zur Induktion von zellulären Immunantworten durch Dendritische Zellen

Scheller, N. (2006) · Publications of the UdS (Saarland University) · doi:10.22028/d291-20854

Obesity alters the immune response to influenza virus infection: a mechanism for immune modulation

Smith, A. G. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/8g6s-9d79

Caractérisation des cellules microgliales adultes et de leur potentiel en immunothérapie des tumeurs cérébrales

Donnou, S., & Couez, D. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)

Modulation of adaptive immunity through acute exercise, metabolism-targeting pharmacological agents, and chronic exercise training

Alley, J. (2021) · doi:10.31274/etd-20210609-3

References

(2014) · ASM Press eBooks · doi:10.1128/9781555815653.refs

Cancer Vaccines

Berzofsky, J. A., Olkhanud, P. B., & Maeng, H. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00014-1

Residual DNAs as adjuvants in existing mRNA vaccines - a multidisciplinary analysisPreprint

Mueller, S. (2025) · doi:10.31219/osf.io/a9xjv_v1

Residual DNAs as adjuvants in existing mRNA vaccines - a multidisciplinary analysisPreprint

Mueller, S. (2025) · doi:10.31219/osf.io/a9xjv_v2

Preclinical gene therapy using recombinant AAV vectors in mouse models of two human diseases

Günes, Y. Ö. (2022) · theses.fr (ABES) · doi:10.70675/52c9a808z1652z42c4zae82zc812b95f1723

Evaluation d'un protocole préclinique d'immunothérapie dirigé contre les tumeurs cérébrales et du potentiel de présentation antigénique croisée des cellules microgliales adultes

Jarry, U. (2011) · HAL

CpG-B ODNs potently induce low levels of IFN-αβ and induce IFN-αβ-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs

Gray, R. C., Kuchtey, J., & Harding, C. V. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006606 · Cited by 37 · see citing works

CpG‐B ODNs induce low levels of IFNαβ and induce IFNαβ‐dependent MHC‐I cross‐presentation in DCs as effectively as CpG‐A, CpG‐C ODNs, and TLR agonists

Gray, R. C., Kuchtey, J., & Harding, C. V. (2007) · The FASEB Journal · doi:10.1096/fasebj.21.6.lb71

Regulation of Interferon Alpha Beta Induction and Dendritic Cell Function by CpG Oligodeoxynucleotides

Gray, R. C. (2008) · OhioLink ETD Center (Ohio Library and Information Network)

IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing

Spadaro, F., Lapenta, C., Donati, S., Abalsamo, L., Barnaba, V., Belardelli, F., Santini, S. M., & Ferrantini, M. (2011) · Blood · doi:10.1182/blood-2011-06-363564 · Cited by 150 · see citing works

CpG DNA Induces a Class II Transactivator-Independent Increase in Class II MHC by Stabilizing Class II MHC mRNA in B Lymphocytes

Kuchtey, J., Pennini, M. E., Pai, R. K., & Harding, C. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2320 · Cited by 19 · see citing works